Quarterly Result10 Aug 2026, 05:00 pm
Kimia Biosciences Declares Unaudited Q1 FY27 Results
AI Summary
Kimia Biosciences Ltd announced its unaudited financial results for the first quarter ended June 30, 2026. The Board of Directors approved and took on record the results at a meeting held on August 10, 2026. A limited review report from the statutory auditors was also placed before the board. The company's primary business segment is Pharmaceuticals.
Key Highlights
- Unaudited financial results for Q1 FY27 declared.
- Results approved by the Board of Directors.
- Limited Review Report from Statutory Auditors submitted.
- Board meeting held on August 10, 2026.
- Company operates in the Pharmaceuticals segment.
Price Impact
More from KIMIABL